Loading...

Mukherjee, Jogeshwar

TitleProfessor In Residence
InstitutionUniversity of California, Irvine
DepartmentRadiological Sciences
Address1001 Health Sciences Road
Irvine CA 92697-3950
Phone(949) 824-2018
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    PET imaging of a4b2 nicotinic receptor upregulation and smoking cessation
    NIH/NIDA R01DA044760Jul 1, 2017 - Apr 30, 2022
    Role: Co-Principal Investigator
    Fluorine-18 Labeled Functional Dopamine Receptor Imaging Agents
    NIH/NIDA R21DA038866Jul 1, 2015 - Jun 30, 2018
    Role: Principal Investigator
    Cyclotron for PET Radiopharmaceuticals
    NIH S10OD012259Apr 19, 2013 - Apr 18, 2014
    Role: Principal Investigator
    Imaging Adrenergic Stimulation of Brown Adipose Tissue
    NIH/NIDDK R21DK092917Sep 1, 2011 - Aug 31, 2014
    Role: Principal Investigator
    PET Imaging Agent for Diabetes Mellitus
    NIH/NIDDK RC1DK087352Sep 19, 2009 - Aug 31, 2012
    Role: Principal Investigator
    Small Animal MicroCT
    NIH/NCRR S10RR024546May 1, 2009 - Apr 30, 2010
    Role: Principal Investigator
    Dopamine D2/D3 Receptor Agonists for PET Imaging
    NIH/NIBIB R01EB006110Aug 6, 2007 - Apr 30, 2012
    Role: Principal Investigator
    18F-Mefway PET for Human Aging and Alzheimer's Disease
    NIH/NIA R33AG030524Jul 1, 2007 - Aug 31, 2014
    Role: Principal Investigator
    18F-Mefway for Imaging Mood Disorders and Alzheimer's Disease
    NIH/NIA R21AG030524Jul 1, 2007 - Aug 31, 2011
    Role: Principal Investigator
    Small Animal PET (microPET)
    NIH/NCRR S10RR019269Apr 1, 2007 - Mar 31, 2008
    Role: Principal Investigator
    PET Imaging Agents for a4b2 Nicotinic Receptors
    NIH/NIA R01AG029479Dec 1, 2006 - Mar 31, 2018
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Samra GK, Dang K, Ho H, Baranwal A, Mukherjee J. Dual targeting agents for Aß plaque/P-glycoprotein and Aß plaque/nicotinic acetylcholine a4ß2* receptors-potential approaches to facilitate Aß plaque removal in Alzheimer's disease brain. Med Chem Res. 2018 Jun; 27(6):1634-1646. PMID: 29937677.
      View in: PubMed
    2. Samra GK, Intskirveli I, Govind AP, Liang C, Lazar R, Green WN, Metherate R, Mukherjee J. Development of fluorescence imaging probes for nicotinic acetylcholine a4ß2* receptors. Bioorg Med Chem Lett. 2017 Dec 17. PMID: 29277457.
      View in: PubMed
    3. Mukherjee J, Lao PJ, Betthauser TJ, Samra GK, Pan ML, Patel IH, Liang C, Metherate R, Christian BT. Human brain imaging of nicotinic acetylcholine a4ß2* receptors using [18 F]Nifene: Selectivity, functional activity, toxicity, aging effects, gender effects, and extrathalamic pathways. J Comp Neurol. 2018 Jan 01; 526(1):80-95. PMID: 28875553.
      View in: PubMed
    4. Betthauser TJ, Hillmer AT, Lao PJ, Ehlerding E, Mukherjee J, Stone CK, Christian BT. Human biodistribution and dosimetry of [18F]nifene, an a4ß2* nicotinic acetylcholine receptor PET tracer. Nucl Med Biol. 2017 Dec; 55:7-11. PMID: 28963927.
      View in: PubMed
    5. Vyas NS, Buchsbaum MS, Lehrer DS, Merrill BM, DeCastro A, Doninger NA, Christian BT, Mukherjee J. D2/D3 dopamine receptor binding with [F-18]fallypride correlates of executive function in medication-naïve patients with schizophrenia. Schizophr Res. 2018 Feb; 192:442-456. PMID: 28576546.
      View in: PubMed
    6. Lao PJ, Betthauser TJ, Tudorascu DL, Barnhart TE, Hillmer AT, Stone CK, Mukherjee J, Christian BT. [18 F]Nifene test-retest reproducibility in first-in-human imaging of a4ß2* nicotinic acetylcholine receptors. Synapse. 2017 08; 71(8). PMID: 28420041.
      View in: PubMed
    7. Coleman RA, Liang C, Patel R, Ali S, Mukherjee J. Brain and Brown Adipose Tissue Metabolism in Transgenic Tg2576 Mice Models of Alzheimer Disease Assessed Using 18F-FDG PET Imaging. Mol Imaging. 2017 Jan 01; 16:1536012117704557. PMID: 28654383.
      View in: PubMed
    8. Mukherjee J, Majji D, Kaur J, Constantinescu CC, Narayanan TK, Shi B, Nour MT, Pan ML. PET radiotracer development for imaging high-affinity state of dopamine D2 and D3 receptors: Binding studies of fluorine-18 labeled aminotetralins in rodents. Synapse. 2017 03; 71(3). PMID: 27864853.
      View in: PubMed
    9. Pithia NK, Liang C, Pan XZ, Pan ML, Mukherjee J. Synthesis and evaluation of (S)-[(18)F]fesetron in the rat brain as a potential PET imaging agent for serotonin 5-HT3 receptors. Bioorg Med Chem Lett. 2016 Apr 15; 26(8):1919-24. PMID: 26979158.
      View in: PubMed
    10. Pan ML, Mukherjee MT, Patel HH, Patel B, Constantinescu CC, Mirbolooki MR, Liang C, Mukherjee J. Evaluation of [11C]TAZA for amyloid ß plaque imaging in postmortem human Alzheimer's disease brain region and whole body distribution in rodent PET/CT. Synapse. 2016 Apr; 70(4):163-76. PMID: 26806100.
      View in: PubMed
    11. Mukherjee J, Baranwal A, Schade KN. Classification of Therapeutic and Experimental Drugs for Brown Adipose Tissue Activation: Potential Treatment Strategies for Diabetes and Obesity. Curr Diabetes Rev. 2016; 12(4):414-428. PMID: 27183844.
      View in: PubMed
    12. Mukherjee J, Bajwa AK, Wooten DW, Hillmer AT, Pan ML, Pandey SK, Saigal N, Christian BT. Comparative assessment of (18) F-Mefway as a serotonin 5-HT1A receptor PET imaging agent across species: Rodents, nonhuman primates, and humans. J Comp Neurol. 2016 May 01; 524(7):1457-71. PMID: 26509362; PMCID: PMC4783179 [Available on 05/01/17].
    13. Mukherjee J, Constantinescu CC, Hoang AT, Jerjian T, Majji D, Pan ML. Dopamine D3 receptor binding of (18)F-fallypride: Evaluation using in vitro and in vivo PET imaging studies. Synapse. 2015 Dec; 69(12):577-91. PMID: 26422464; PMCID: PMC4624469 [Available on 12/01/16].
    14. Baranwal A, Mukherjee J. (18)F-Fluorodeoxyglucamines: Reductive amination of hydrophilic (18)F-fluoro-2-deoxyglucose with lipophilic amines for the development of potential PET imaging agents. Bioorg Med Chem Lett. 2015 Aug 01; 25(15):2902-6. PMID: 26048782; PMCID: PMC4469266.
    15. Schade KN, Baranwal A, Liang C, Mirbolooki MR, Mukherjee J. Preliminary evaluation of ß3-adrenoceptor agonist-induced 18F-FDG metabolic activity of brown adipose tissue in obese Zucker rat. Nucl Med Biol. 2015 Aug; 42(8):691-4. PMID: 25934347; PMCID: PMC4481135.
    16. Thio JP, Liang C, Bajwa AK, Wooten DW, Christian BT, Mukherjee J. Synthesis and Evaluation of Mefway Analogs as Ligands for Serotonin 5HT1A Receptors. Med Chem Res. 2015 Apr; 24(4):1480-1486. PMID: 25750500.
      View in: PubMed
    17. Baranwal A, Mirbolooki MR, Mukherjee J. Initial Assessment of ß3-Adrenoceptor-Activated Brown Adipose Tissue in Streptozotocin-Induced Type 1 Diabetes Rodent Model Using [18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Mol Imaging. 2015; 14(12):22-33. PMID: 26637263.
      View in: PubMed
    18. Hillmer AT, Wooten DW, Bajwa AK, Higgins AT, Lao PJ, Betthauser TJ, Barnhart TE, Rowley HA, Stone CK, Johnson SC, Mukherjee J, Christian BT. First-in-human evaluation of 18F-mefway, a PET radioligand specific to serotonin-1A receptors. J Nucl Med. 2014 Dec; 55(12):1973-9. PMID: 25453045; PMCID: PMC4316674.
    19. Mirbolooki MR, Schade KN, Constantinescu CC, Pan ML, Mukherjee J. Enhancement of 18F-fluorodeoxyglucose metabolism in rat brain frontal cortex using a ß3 adrenoceptor agonist. Synapse. 2015 Feb; 69(2):96-8. PMID: 25347981; PMCID: PMC4275345.
    20. Wooten DW, Hillmer AT, Murali D, Barnhart TE, Thio JP, Bajwa AK, Bonab AA, Normandin MD, Schneider ML, Mukherjee J, Christian BT. Initial in vivo PET imaging of 5-HT1A receptors with 3-[(18)F]mefway. Am J Nucl Med Mol Imaging. 2014; 4(5):483-9. PMID: 25143866; PMCID: PMC4138142.
    21. Kaur J, Khararjian A, Coleman RA, Constantinescu CC, Pan ML, Mukherjee J. Spinal cord dopamine D2/D3 receptors: in vivo and ex vivo imaging in the rat using (18)F/(11)C-fallypride. Nucl Med Biol. 2014 Nov-Dec; 41(10):841-7. PMID: 25199843; PMCID: PMC4192035.
    22. Tang W, Kuruvilla SA, Galitovskiy V, Pan ML, Grando SA, Mukherjee J. Targeting histone deacetylase in lung cancer for early diagnosis: (18)F-FAHA PET/CT imaging of NNK-treated A/J mice model. Am J Nucl Med Mol Imaging. 2014; 4(4):324-32. PMID: 24982818; PMCID: PMC4074498.
    23. Kuruvilla SA, Hillmer AT, Wooten DW, Patel A, Christian BT, Mukherjee J. Synthesis and evaluation of 2-(18)F-fluoro-5-iodo-3-[2-(S)-3,4-dehydropyrrolinylmethoxy]pyridine ((18)F-Niofene) as a potential imaging agent for nicotinic a4ß2 receptors. Am J Nucl Med Mol Imaging. 2014; 4(4):354-64. PMID: 24982821; PMCID: PMC4074501.
    24. Garcia A, Venugopal A, Pan ML, Mukherjee J. Imaging pancreas in healthy and diabetic rodent model using [18F]fallypride positron emission tomography/computed tomography. Diabetes Technol Ther. 2014 Oct; 16(10):640-3. PMID: 24828096; PMCID: PMC4183907.
    25. Pandey S, Venugopal A, Kant R, Coleman R, Mukherjee J. ¹²4I-Epidepride: a PET radiotracer for extended imaging of dopamine D2/D3 receptors. Nucl Med Biol. 2014 May-Jun; 41(5):426-31. PMID: 24602412; PMCID: PMC4004701.
    26. Tahara N, Mukherjee J, de Haas HJ, Petrov AD, Tawakol A, Haider N, Tahara A, Constantinescu CC, Zhou J, Boersma HH, Imaizumi T, Nakano M, Finn A, Fayad Z, Virmani R, Fuster V, Bosca L, Narula J. 2-deoxy-2-[18F]fluoro-D-mannose positron emission tomography imaging in atherosclerosis. Nat Med. 2014 Feb; 20(2):215-9. PMID: 24412923.
      View in: PubMed
    27. Pandey SK, Kaur J, Easwaramoorthy B, Shah A, Coleman R, Mukherjee J. Multimodality imaging probe for positron emission tomography and fluorescence imaging studies. Mol Imaging. 2014; 13:1-7. PMID: 24824856.
      View in: PubMed
    28. Baranwal A, Patel HH, Mukherjee J. 18F-Fluorodeoxyglycosylamines: Maillard reaction of 18F-fluorodeoxyglucose with biological amines. J Labelled Comp Radiopharm. 2014 Feb; 57(2):86-91. PMID: 24327460.
      View in: PubMed
    29. Mirbolooki MR, Upadhyay SK, Constantinescu CC, Pan ML, Mukherjee J. Adrenergic pathway activation enhances brown adipose tissue metabolism: a [¹8F]FDG PET/CT study in mice. Nucl Med Biol. 2014 Jan; 41(1):10-6. PMID: 24090673; PMCID: PMC3840120.
    30. Potkin SG, Keator DB, Kesler-West ML, Nguyen DD, van Erp TG, Mukherjee J, Shah N, Preda A. D2 receptor occupancy following lurasidone treatment in patients with schizophrenia or schizoaffective disorder. CNS Spectr. 2014 Apr; 19(2):176-81. PMID: 24073841.
      View in: PubMed
    31. Hillmer AT, Wooten DW, Farhoud M, Higgins AT, Lao PJ, Barnhart TE, Mukherjee J, Christian BT. PET imaging of acetylcholinesterase inhibitor-induced effects on a4ß2 nicotinic acetylcholine receptor binding. Synapse. 2013 Dec; 67(12):882-6. PMID: 23913347; PMCID: PMC3806056.
    32. Hillmer AT, Wooten DW, Slesarev MS, Ahlers EO, Barnhart TE, Schneider ML, Mukherjee J, Christian BT. Measuring a4ß2* nicotinic acetylcholine receptor density in vivo with [(18)F]nifene PET in the nonhuman primate. J Cereb Blood Flow Metab. 2013 Nov; 33(11):1806-14. PMID: 23942367; PMCID: PMC3824181.
    33. Upadhyay SK, Eckel-Mahan KL, Mirbolooki MR, Tjong I, Griffey SM, Schmunk G, Koehne A, Halbout B, Iadonato S, Pedersen B, Borrelli E, Wang PH, Mukherjee J, Sassone-Corsi P, Chandy KG. Selective Kv1.3 channel blocker as therapeutic for obesity and insulin resistance. Proc Natl Acad Sci U S A. 2013 Jun 11; 110(24):E2239-48. PMID: 23729813; PMCID: PMC3683782.
    34. Saigal N, Bajwa AK, Faheem SS, Coleman RA, Pandey SK, Constantinescu CC, Fong V, Mukherjee J. Evaluation of serotonin 5-HT(1A) receptors in rodent models using [¹8F]mefway PET. Synapse. 2013 Sep; 67(9):596-608. PMID: 23504990; PMCID: PMC3744326.
    35. Pithia N, Gulati N, Pandey S, Coleman R, Kant R, Mukherjee J. Synthesis and biological evaluation of 18F-Norfallypride in the rodent brain using PET imaging. Nucl Med Biol. 2013 Jul; 40(5):697-704. PMID: 23562464; PMCID: PMC3752033.
    36. Constantinescu CC, Sevrioukov E, Garcia A, Pan ML, Mukherjee J. Evaluation of [18F]Mefway biodistribution and dosimetry based on whole-body PET imaging of mice. Mol Imaging Biol. 2013 Apr; 15(2):222-9. PMID: 22833323; PMCID: PMC3808848.
    37. Wooten DW, Hillmer AT, Moirano JM, Tudorascu DL, Ahlers EO, Slesarev MS, Barnhart TE, Mukherjee J, Schneider ML, Christian BT. 5-HT1A sex based differences in Bmax, in vivo KD, and BPND in the nonhuman primate. Neuroimage. 2013 Aug 15; 77:125-32. PMID: 23537936; PMCID: PMC3654069.
    38. Hillmer AT, Wooten DW, Farhoud M, Barnhart TE, Mukherjee J, Christian BT. The effects of lobeline on a4ß2* nicotinic acetylcholine receptor binding and uptake of [(18)F]nifene in rats. J Neurosci Methods. 2013 Apr 15; 214(2):163-9. PMID: 23370310; PMCID: PMC3644313.
    39. Constantinescu CC, Garcia A, Mirbolooki MR, Pan ML, Mukherjee J. Evaluation of [18F]Nifene biodistribution and dosimetry based on whole-body PET imaging of mice. Nucl Med Biol. 2013 Feb; 40(2):289-94. PMID: 23265670; PMCID: PMC3557576.
    40. Nalbandian A, Llewellyn KJ, Badadani M, Yin HZ, Nguyen C, Katheria V, Watts G, Mukherjee J, Vesa J, Caiozzo V, Mozaffar T, Weiss JH, Kimonis VE. A progressive translational mouse model of human valosin-containing protein disease: the VCP(R155H/+) mouse. Muscle Nerve. 2013 Feb; 47(2):260-70. PMID: 23169451; PMCID: PMC3556223.
    41. Mirbolooki MR, Constantinescu CC, Pan ML, Mukherjee J. Targeting presynaptic norepinephrine transporter in brown adipose tissue: a novel imaging approach and potential treatment for diabetes and obesity. Synapse. 2013 Feb; 67(2):79-93. PMID: 23080264; PMCID: PMC3808851.
    42. Pichika R, Kuruvilla SA, Patel N, Vu K, Sinha S, Easwaramoorthy B, Narayanan TK, Shi B, Christian B, Mukherjee J. Nicotinic a4ß2 receptor imaging agents. Part IV. Synthesis and biological evaluation of 3-(2-(S)-3,4-dehydropyrrolinyl methoxy)-5-(3'-¹8F-fluoropropyl)pyridine (¹8F-Nifrolene) using PET. Nucl Med Biol. 2013 Jan; 40(1):117-25. PMID: 23141552; PMCID: PMC3514651.
    43. Pandey SK, Pan S, Kant R, Kuruvilla SA, Pan ML, Mukherjee J. Synthesis and evaluation of 3-¹²³I-iodo-5-[2-(S)-3-pyrrolinylmethoxy]-pyridine (niodene) as a potential nicotinic a4ß2 receptor imaging agent. Bioorg Med Chem Lett. 2012 Dec 15; 22(24):7610-4. PMID: 23116890; PMCID: PMC3508149.
    44. Nalbandian A, Llewellyn KJ, Kitazawa M, Yin HZ, Badadani M, Khanlou N, Edwards R, Nguyen C, Mukherjee J, Mozaffar T, Watts G, Weiss J, Kimonis VE. The homozygote VCP(R¹55H/R¹55H) mouse model exhibits accelerated human VCP-associated disease pathology. PLoS One. 2012; 7(9):e46308. PMID: 23029473; PMCID: PMC3460820.
    45. Hillmer AT, Wooten DW, Slesarev MS, Ahlers EO, Barnhart TE, Murali D, Schneider ML, Mukherjee J, Christian BT. PET imaging of a4ß2* nicotinic acetylcholine receptors: quantitative analysis of 18F-nifene kinetics in the nonhuman primate. J Nucl Med. 2012 Sep; 53(9):1471-80. PMID: 22851633; PMCID: PMC3580212.
    46. Wooten DW, Hillmer AT, Moirano JM, Ahlers EO, Slesarev M, Barnhart TE, Mukherjee J, Schneider ML, Christian BT. Measurement of 5-HT(1A) receptor density and in-vivo binding parameters of [(18)F]mefway in the nonhuman primate. J Cereb Blood Flow Metab. 2012 Aug; 32(8):1546-58. PMID: 22472611; PMCID: PMC3421091.
    47. Bieszczad KM, Kant R, Constantinescu CC, Pandey SK, Kawai HD, Metherate R, Weinberger NM, Mukherjee J. Nicotinic acetylcholine receptors in rat forebrain that bind ¹8F-nifene: relating PET imaging, autoradiography, and behavior. Synapse. 2012 May; 66(5):418-34. PMID: 22213342; PMCID: PMC3292694.
    48. Reist C, Wu JC, Lilja Y, Mukherjee J, Gripeos D, Constantinescu C, Raggi MA, Mercolini L, Ozdemir V. Ketoconazole-associated preferential increase in dopamine D2 receptor occupancy in striatum compared to pituitary in vivo: role for drug transporters? J Clin Psychopharmacol. 2012 Feb; 32(1):110-3. PMID: 22198458.
      View in: PubMed
    49. Mirbolooki MR, Constantinescu CC, Pan ML, Mukherjee J. Quantitative assessment of brown adipose tissue metabolic activity and volume using 18F-FDG PET/CT and β3-adrenergic receptor activation. EJNMMI Res. 2011 Dec 01; 1(1):30. PMID: 22214183; PMCID: PMC3250993.
    50. Nalbandian A, Donkervoort S, Dec E, Badadani M, Katheria V, Rana P, Nguyen C, Mukherjee J, Caiozzo V, Martin B, Watts GD, Vesa J, Smith C, Kimonis VE. The multiple faces of valosin-containing protein-associated diseases: inclusion body myopathy with Paget's disease of bone, frontotemporal dementia, and amyotrophic lateral sclerosis. J Mol Neurosci. 2011 Nov; 45(3):522-31. PMID: 21892620.
      View in: PubMed
    51. Pichika R, Easwaramoorthy B, Christian BT, Shi B, Narayanan TK, Collins D, Mukherjee J. Nicotinic a4ß2 receptor imaging agents. Part III. Synthesis and biological evaluation of 3-(2-(S)-azetidinylmethoxy)-5-(3'-18F-fluoropropyl)pyridine (18F-nifzetidine). Nucl Med Biol. 2011 Nov; 38(8):1183-92. PMID: 21831652; PMCID: PMC3217100.
    52. Wooten D, Hillmer A, Murali D, Barnhart T, Schneider ML, Mukherjee J, Christian BT. An in vivo comparison of cis- and trans-[18F]mefway in the nonhuman primate. Nucl Med Biol. 2011 Oct; 38(7):925-32. PMID: 21741252; PMCID: PMC3190069.
    53. Garcia A, Mirbolooki MR, Constantinescu C, Pan ML, Sevrioukov E, Milne N, Wang PH, Lakey J, Chandy KG, Mukherjee J. 18F-Fallypride PET of pancreatic islets: in vitro and in vivo rodent studies. J Nucl Med. 2011 Jul; 52(7):1125-32. PMID: 21680697.
      View in: PubMed
    54. Kant R, Constantinescu CC, Parekh P, Pandey SK, Pan ML, Easwaramoorthy B, Mukherjee J. Evaluation of F-nifene binding to a4ß2 nicotinic receptors in the rat brain using microPET imaging. EJNMMI Res. 2011 Jun 01; 1. PMID: 22039577.
      View in: PubMed
    55. Constantinescu CC, Coleman RA, Pan ML, Mukherjee J. Striatal and extrastriatal microPET imaging of D2/D3 dopamine receptors in rat brain with [¹8F]fallypride and [¹8F]desmethoxyfallypride. Synapse. 2011 Aug; 65(8):778-87. PMID: 21218455; PMCID: PMC3107916.
    56. Badadani M, Nalbandian A, Watts GD, Vesa J, Kitazawa M, Su H, Tanaja J, Dec E, Wallace DC, Mukherjee J, Caiozzo V, Warman M, Kimonis VE. VCP associated inclusion body myopathy and paget disease of bone knock-in mouse model exhibits tissue pathology typical of human disease. PLoS One. 2010 Oct 05; 5(10). PMID: 20957154.
      View in: PubMed
    57. Nguyen VL, Pichika R, Bhakta PH, Kant R, Mukherjee J. (R)-N-Methyl-3-(3'-[F]fluoropropyl)phenoxy)-3-phenylpropanamine (F-MFP3) as a potential PET imaging agent for norepinephrine transporter. J Labelled Comp Radiopharm. 2010 Feb 09; 53(4):172-177. PMID: 20495670.
      View in: PubMed
    58. Lee B, London ED, Poldrack RA, Farahi J, Nacca A, Monterosso JR, Mumford JA, Bokarius AV, Dahlbom M, Mukherjee J, Bilder RM, Brody AL, Mandelkern MA. Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity. J Neurosci. 2009 Nov 25; 29(47):14734-40. PMID: 19940168; PMCID: PMC2822639.
    59. Constantinescu CC, Mukherjee J. Performance evaluation of an Inveon PET preclinical scanner. Phys Med Biol. 2009 May 07; 54(9):2885-99. PMID: 19384008; PMCID: PMC2838767.
    60. Airaksinen AJ, Nag S, Finnema SJ, Mukherjee J, Chattopadhyay S, Gulyás B, Farde L, Halldin C. [11C]cyclopropyl-FLB 457: a PET radioligand for low densities of dopamine D2 receptors. Bioorg Med Chem. 2008 Jul 01; 16(13):6467-73. PMID: 18534857; PMCID: PMC2531229.
    61. Singhal T, Narayanan TK, Jain V, Mukherjee J, Mantil J. 11C-L-methionine positron emission tomography in the clinical management of cerebral gliomas. Mol Imaging Biol. 2008 Jan-Feb; 10(1):1-18. PMID: 17957408.
      View in: PubMed
    62. Easwaramoorthy B, Pichika R, Collins D, Potkin SG, Leslie FM, Mukherjee J. Effect of acetylcholinesterase inhibitors on the binding of nicotinic alpha4beta2 receptor PET radiotracer, (18)F-nifene: A measure of acetylcholine competition. Synapse. 2007 Jan; 61(1):29-36. PMID: 17068780.
      View in: PubMed
    63. Saigal N, Pichika R, Easwaramoorthy B, Collins D, Christian BT, Shi B, Narayanan TK, Potkin SG, Mukherjee J. Synthesis and biologic evaluation of a novel serotonin 5-HT1A receptor radioligand, 18F-labeled mefway, in rodents and imaging by PET in a nonhuman primate. J Nucl Med. 2006 Oct; 47(10):1697-706. PMID: 17015907.
      View in: PubMed
    64. Buchsbaum MS, Christian BT, Lehrer DS, Narayanan TK, Shi B, Mantil J, Kemether E, Oakes TR, Mukherjee J. D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia. Schizophr Res. 2006 Jul; 85(1-3):232-44. PMID: 16713185.
      View in: PubMed
    65. Pichika R, Easwaramoorthy B, Collins D, Christian BT, Shi B, Narayanan TK, Potkin SG, Mukherjee J. Nicotinic alpha4beta2 receptor imaging agents: part II. Synthesis and biological evaluation of 2-[18F]fluoro-3-[2-((S)-3-pyrrolinyl)methoxy]pyridine (18F-nifene) in rodents and imaging by PET in nonhuman primate. Nucl Med Biol. 2006 Apr; 33(3):295-304. PMID: 16631077.
      View in: PubMed
    66. Shikhaliev PM, Xu T, Ducote JL, Easwaramoorthy B, Mukherjee J, Molloi S. Positron autoradiography for intravascular imaging: feasibility evaluation. Phys Med Biol. 2006 Feb 21; 51(4):963-79. PMID: 16467590.
      View in: PubMed
    67. Schneider ML, Moore CF, Barnhart TE, Larson JA, DeJesus OT, Mukherjee J, Nickles RJ, Converse AK, Roberts AD, Kraemer GW. Moderate-level prenatal alcohol exposure alters striatal dopamine system function in rhesus monkeys. Alcohol Clin Exp Res. 2005 Sep; 29(9):1685-97. PMID: 16205369.
      View in: PubMed
    68. Mukherjee J, Christian BT, Narayanan TK, Shi B, Collins D. Measurement of d-amphetamine-induced effects on the binding of dopamine D-2/D-3 receptor radioligand, 18F-fallypride in extrastriatal brain regions in non-human primates using PET. Brain Res. 2005 Jan 25; 1032(1-2):77-84. PMID: 15680944.
      View in: PubMed
    69. Chattopadhyay S, Xue B, Collins D, Pichika R, Bagnera R, Leslie FM, Christian BT, Shi B, Narayanan TK, Potkin SG, Mukherjee J. Synthesis and evaluation of nicotine alpha4beta2 receptor radioligand, 5-(3'-18F-fluoropropyl)-3-(2-(S)-pyrrolidinylmethoxy)pyridine, in rodents and PET in nonhuman primate. J Nucl Med. 2005 Jan; 46(1):130-40. PMID: 15632043.
      View in: PubMed
    70. Mukherjee J, Narayanan TK, Christian BT, Shi B, Yang ZY. Binding characteristics of high-affinity dopamine D2/D3 receptor agonists, 11C-PPHT and 11C-ZYY-339 in rodents and imaging in non-human primates by PET. Synapse. 2004 Nov; 54(2):83-91. PMID: 15352133.
      View in: PubMed
    71. Shi B, Narayanan TK, Christian BT, Chattopadhyay S, Mukherjee J. Synthesis and biological evaluation of the binding of dopamine D2/D3 receptor agonist, (R,S)-5-hydroxy-2-(N-propyl-N-(5'-(18)F-fluoropentyl)aminotetralin ((18)F-5-OH-FPPAT) in rodents and nonhuman primates. Nucl Med Biol. 2004 Apr; 31(3):303-11. PMID: 15028242.
      View in: PubMed
    72. Christian BT, Narayanan T, Shi B, Morris ED, Mantil J, Mukherjee J. Measuring the in vivo binding parameters of [18F]-fallypride in monkeys using a PET multiple-injection protocol. J Cereb Blood Flow Metab. 2004 Mar; 24(3):309-22. PMID: 15091112.
      View in: PubMed
    73. Mukherjee J, Shi B, Christian BT, Chattopadhyay S, Narayanan TK. 11C-Fallypride: radiosynthesis and preliminary evaluation of a novel dopamine D2/D3 receptor PET radiotracer in non-human primate brain. Bioorg Med Chem. 2004 Jan 02; 12(1):95-102. PMID: 14697774.
      View in: PubMed
    74. Mukherjee J, Christian BT, Dunigan KA, Shi B, Narayanan TK, Satter M, Mantil J. Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors. Synapse. 2002 Dec 01; 46(3):170-88. PMID: 12325044.
      View in: PubMed
    75. Narayanan TK, Said S, Mukherjee J, Christian B, Satter M, Dunigan K, Shi B, Jacobs M, Bernstein T, Padma M, Mantil J. A comparative study on the uptake and incorporation of radiolabeled methionine, choline and fluorodeoxyglucose in human astrocytoma. Mol Imaging Biol. 2002 Mar; 4(2):147-56. PMID: 14537137.
      View in: PubMed
    76. Mukherjee J, Christian BT, Narayanan TK, Shi B, Mantil J. Evaluation of dopamine D-2 receptor occupancy by clozapine, risperidone, and haloperidol in vivo in the rodent and nonhuman primate brain using 18F-fallypride. Neuropsychopharmacology. 2001 Oct; 25(4):476-88. PMID: 11557161.
      View in: PubMed
    Jogeshwar's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _